Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150033/S224

Micra Scalable Catheter Delivery System (Micra AV TPS MC1AVR1; Micra AV2 TPS MC2AVR1; Micra TPS MC1VR01; Micra VR2 TPS

Medtronic, Inc. · Decision date Jun 4, 2026

FDA DECISIONP150033/S224

What did the FDA approve?

FDA records P150033/S224 as a supplement to PMA P150033, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jun 4, 2026.

FDA approval order statement

Approval for design and subsequent process changes to the Micra Delivery Catheter contained within the Micra Transcatheter Pacing System (TPS).
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jun 4, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150033/S224
Regulatory pathway
PMA supplement
Product code
PNJ
Decision code
APPR
Decision date
Jun 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Leadless pacemaker.

Product code
PNJ
FDA device class
3

For the original device and its historical approval scope, see PMA P150033. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P150033 · Original PMA

    MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM

  2. P150033/S213 · Related supplement

    MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM

  3. P150033/S214 · Related supplement

    Micra AV TPS MC1AVR1; Micra AV2 TPS MC2AVR1; Micra TPS MC1VR01; Micra VR2 TPS MC2VR01

  4. P150033/S212 · Related supplement

    Micra Transcatheter Pacing System (Micra AV/VR and Micra AV2/VR2)

  5. P150033/S208 · Related supplement

    MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM

  6. P150033/S215 · Related supplement

    Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)

  7. P150033/S216 · Related supplement

    Miera AV TPS (MC1AVR1); Miera A V2 TPS (MC2AVR1); Miera TPS (MC1VR01); Miera VR2 TPS (MC2VR01)

  8. P150033/S217 · Related supplement

    Micra Transcatheter Pacing Systems

  9. P150033/S218 · Related supplement

    Micra A V2 TPS (MC2AVR1); Micra VR2 TPS (MC2VR01)

  10. P150033/S219 · Related supplement

    Micra AV TPS MC1AVR1 PNJ Micra AV2 TPS MC2AVR1 PNJ Micra TPS MC1VR01 PNJ Micra VR2 TPS MC2VR01

  11. P150033/S220 · Related supplement

    Micra AV2 TPS; Micra VR2 TPS

  12. P150033/S221 · Related supplement

    Micra Transcatheter Pacing System (MC1VR01), Micra AV Transcatheter Pacing System (MC1AVR1), Micra VR2 Transcatheter Pac

  13. P150033/S222 · Related supplement

    Miera AV TPS; Miera TPS

  14. P150033/S224 received

    Application receipt date recorded by FDA.

  15. P150033/S225 · Related supplement

    Micra Transcatheter Pacing System

  16. P150033/S223 · Related supplement

    Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)

  17. P150033/S226 · Related supplement

    Micra AV TPS; Micra AV2 TPS; Micra TPS; Micra VR2 TPS

  18. P150033/S227 · Related supplement

    Micra Cathode Press Station 2

  19. P150033/S224 · FDA decision

    Real-Time Process

  20. P150033/S228 · Related supplement

    Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)

  21. P150033/S229 · Related supplement

    Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)

  22. P150033/S230 · Related supplement

    Micra Functional Testing on pNGHT and NGHT

Timeline entries are records held by MedtechLedger for P150033. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150033

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA approvalApr 6, 2016FDA
Medtronic, Inc.PMA supplementJul 29, 2025FDA
Medtronic, Inc.PMA supplementAug 12, 2025FDA
Medtronic, Inc.PMA supplementAug 15, 2025FDA
Medtronic, Inc.PMA supplementAug 20, 2025FDA
Medtronic, Inc.PMA supplementAug 21, 2025FDA
Medtronic, Inc.PMA supplementSep 5, 2025FDA
Medtronic, Inc.PMA supplementNov 25, 2025FDA
Medtronic, Inc.PMA supplementDec 2, 2025FDA
Medtronic, Inc.PMA supplementDec 3, 2025FDA
Medtronic, Inc.PMA supplementFeb 10, 2026FDA
Medtronic, Inc.PMA supplementFeb 11, 2026FDA
Medtronic, Inc.PMA supplementFeb 23, 2026FDA
Medtronic, Inc.PMA supplementApr 22, 2026FDA
Medtronic, Inc.PMA supplementApr 30, 2026FDA
Medtronic, Inc.PMA supplementApr 30, 2026FDA
Medtronic, Inc.PMA supplementMay 8, 2026FDA
Medtronic, Inc.PMA supplementJul 31, 2026FDA
Medtronic, Inc.PMA supplementJul 31, 2026FDA
Medtronic, Inc.PMA supplementSep 8, 2026FDA

Explore the linked device profile

Other records with product code PNJ

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 21, 2026FDA
ABBOTT MEDICALPMA supplementAug 27, 2026FDA
ABBOTT MEDICALPMA supplementJul 21, 2026FDA
ABBOTT MEDICALPMA supplementJun 17, 2026FDA
ABBOTT MEDICALPMA supplementJun 11, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records